Xeris Biopharma (XERS) Insider Trading & Ownership $4.38 +0.22 (+5.29%) Closing price 04:00 PM EasternExtended Trading$4.46 +0.09 (+1.94%) As of 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Xeris Biopharma (NASDAQ:XERS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.56%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$10,155.45Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$217,200.00 Get XERS Insider Trade Alerts Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address XERS Insider Buying and Selling by Quarter Remove Ads Xeris Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/20/2025Beth HechtInsiderSell40,000$5.43$217,200.00 8/9/2024John P SchmidDirectorBuy4,285$2.37$10,155.45 (Data available from 1/1/2013 forward) XERS Insider Trading Activity - Frequently Asked Questions Who is on Xeris Biopharma's Insider Roster? The list of insiders at Xeris Biopharma includes Beth Hecht, Jeffrey W Sherman, John P Schmid, John Patrick Shannon Jr, and Paul R Edick. Learn more on insiders at XERS. What percentage of Xeris Biopharma stock is owned by insiders? 4.56% of Xeris Biopharma stock is owned by insiders. Learn more on XERS's insider holdings. Which Xeris Biopharma insiders have been buying company stock? The following insiders have purchased XERS shares in the last 24 months: Jeffrey W Sherman ($10,098.00), John P Schmid ($29,690.45), John Patrick Shannon Jr ($50,461.16), and Paul R Edick ($23,800.00). How much insider buying is happening at Xeris Biopharma? Insiders have purchased a total of 61,454 XERS shares in the last 24 months for a total of $114,049.61 bought. Which Xeris Biopharma insiders have been selling company stock? The following insider sold XERS shares in the last 24 months: Beth Hecht ($217,200.00). How much insider selling is happening at Xeris Biopharma? Insiders have sold a total of 40,000 Xeris Biopharma shares in the last 24 months for a total of $217,200.00 sold. Xeris Biopharma Key ExecutivesMr. Paul R. Edick (Age 68)Chairman & CEO Compensation: $1.21MMr. John P. Shannon (Age 62)President & COO Compensation: $918.15kMr. Steven M. Pieper (Age 46)Chief Financial Officer Compensation: $681.14kMs. Beth P. Hecht J.D. (Age 60)Chief Legal Officer & Corporate Secretary Compensation: $695.44kDr. Kenneth E. Johnson Pharm. D. (Age 61)Pharm.D., Senior VP of Global Development & Medical Affairs Compensation: $596.97kMs. Allison WeySenior Vice President of Investor Relations & Corporate CommunicationsMr. Kevin McCullochChief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Protagonist Therapeutics Insider Transactions Catalyst Pharmaceuticals Insider Transactions Merus Insider Transactions Apellis Pharmaceuticals Insider Transactions Scholar Rock Insider Transactions Crinetics Pharmaceuticals Insider Transactions Immunovant Insider Transactions ACADIA Pharmaceuticals Insider Transactions Viking Therapeutics Insider Transactions Xenon Pharmaceuticals Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own Stock This page (NASDAQ:XERS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xeris Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XERS Stock Free XERS Stock Alerts